BioTech/Drugs - Oklahoma City, OK, US
R&D Program Manager
Contact Nick Stefanko
Senior Scientist
Contact Ziad Kawar
Executive VP and COO
Contact Russell Rother
CEO and Chairman of the BOD
Contact Scott Rollins
Associate Director, Clinical Operations
Contact Amy Ascher
Tetherex Pharmaceuticals focuses on the development of novel selectin inhibitor products to treat thrombosis, inflammatory diseases and cancer.
Gmail
Apache
Google Tag Manager
Google Apps
GoDaddy Hosting